- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02549976
Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis (DESTIN)
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Background: Crohn's disease (CD) is a chronic inflammatory disorder of the bowel that is characterized by periods of clinical remission alternating with periods of recurrence. Persistent inflammation is believed to lead to progressive bowel damage that, over time, will manifest in the development of strictures, fistulae, and abscesses. The recent development of the Lemann index allows us to precisely assess digestive damage in CD. The aim of the present study is to evaluate digestive damage and associated predictive factors in CD 5 to 10 years after diagnosis.
Methods: Prospective, multicenter, international, transversal, observational study. Patients who completed the RAPID trial (evaluating the benefits on the course of CD of an early prescription of azathioprine compared with conventional step-care therapy) will be eligible. Digestive damage will be assessed using methods described in the Lemann index protocol, dependent on CD location (abdominal MRI obligatory). The total duration of study participation for 1patient will be ≤4 months.
Aims: The primary objective is to evaluate digestive damage in CD 5 to 10 years after diagnosis in the GETAID centers included in the RAPID study. Secondary objective is to identify predictive factors of the evolution digestive damage.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Clermont-ferrand, Frankrig, 63003
- CHU Clermont-Ferrand
-
Clichy, Frankrig, 92110
- Hôpital Beaujon
-
Lille, Frankrig
- CHRU Lille
-
Nice, Frankrig, 06202
- CHU Nice
-
Paris, Frankrig, 75012
- Hôpital Saint-Antoine
-
Paris, Frankrig, 75010
- Hopital Saint Louis
-
Paris, Frankrig, 75014
- IMM
-
Pessac, Frankrig, 33700
- CHU Bordeaux - Pessac
-
Toulouse, Frankrig, 31403
- CHU Toulouse
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Male or female patients over 18 years old
- Active or Inactive Crohn's Disease
- Previously enrolled in RAPID clinical trial
Exclusion Criteria:
- Pregnant or nursing woman
- Patient with a contraindication or who decline to have study exams (MRI and endoscopy)
- Other medical or psychiatric or serious chronic conditions or according to the physician's discretion that could affect the patient's cooperation or the capacity to follow study procedures.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Evaluation group
Digestive damage will be assessed on patients by using the methods described in the Lemann index protocol, dependant of Crohn's disease locations. All patients will have clinical examination and abdominal magnetic resonance imaging analyses. Upper endoscopy, colonoscopy, and pelvic magnetic resonance imaging analyses will be performed according to disease locations :
|
Abdominal MRI to realize within 4 months following inclusion
Upper endoscopy to realize within 4 months following inclusion
Colonoscopy to realize within 4 months following inclusion
Pelvic MRI to realize within 4 months following inclusion
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Digestive damage
Tidsramme: 5 to 10 years after diagnosis
|
Evaluate digestive damage in Crohn's Disease by using Lemann Index
|
5 to 10 years after diagnosis
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Predictive factors of the digestive damage evolution
Tidsramme: 5 to 10 years after diagnosis
|
Evaluate digestive damage per organ (upper intestinal tract, small bowel, colon or rectum, anal or perianal) by using Lemann Index
|
5 to 10 years after diagnosis
|
Predictive factors of the digestive damage evolution
Tidsramme: 5 to 10 years after diagnosis
|
Determine correlation between Lemann Index and factors measured at diagnosis and then 5 to 10 years after diagnosis.
|
5 to 10 years after diagnosis
|
Variation of Lemann Index
Tidsramme: 5 to 10 years after diagnosis
|
Variation of Lemann Index 5 to 10 years after diagnosis
|
5 to 10 years after diagnosis
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Benjamin Pariente, MD, PhD, Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
- Ledende efterforsker: Jacques Cosnes, MD, Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Publikationer og nyttige links
Generelle publikationer
- Cosnes J, Bourrier A, Laharie D, Nahon S, Bouhnik Y, Carbonnel F, Allez M, Dupas JL, Reimund JM, Savoye G, Jouet P, Moreau J, Mary JY, Colombel JF; Groupe d'Etude Therapeutique des Affections Inflammatoires du Tube Digestif (GETAID). Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. Gastroenterology. 2013 Oct;145(4):758-65.e2; quiz e14-5. doi: 10.1053/j.gastro.2013.04.048. Epub 2013 Apr 30.
- Pariente B, Mary JY, Danese S, Chowers Y, De Cruz P, D'Haens G, Loftus EV Jr, Louis E, Panes J, Scholmerich J, Schreiber S, Vecchi M, Branche J, Bruining D, Fiorino G, Herzog M, Kamm MA, Klein A, Lewin M, Meunier P, Ordas I, Strauch U, Tontini GE, Zagdanski AM, Bonifacio C, Rimola J, Nachury M, Leroy C, Sandborn W, Colombel JF, Cosnes J. Development of the Lemann index to assess digestive tract damage in patients with Crohn's disease. Gastroenterology. 2015 Jan;148(1):52-63.e3. doi: 10.1053/j.gastro.2014.09.015. Epub 2014 Sep 21.
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2015-4
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Crohns sygdom
-
Asan Medical CenterIkke rekrutterer endnuCrohns sygdom | Terapeutisk lægemiddelovervågning | Infliximab | Perianal fistel på grund af Crohns sygdom | Magnetic Resonance Novel Index for Fistel Imaging i Crohn's Disease Score
Kliniske forsøg med Abdominal MRI
-
Ain Shams UniversityAfsluttet
-
South Valley UniversityAfsluttetProlaps GenitalEgypten
-
Turku University HospitalAfsluttet
-
Hospital de GranollersAfsluttetAkut divertikulitisSpanien
-
Lyndra Inc.AfsluttetSund og rask | Alzheimers sygdom | Mave-retentionAustralien
-
Princess Anna Mazowiecka Hospital, Warsaw, PolandJagiellonian University; Ujastek Obstetrics and Gynaecology Hospital; University...UkendtNekrotiserende enterocolitisPolen
-
Buddhist Tzu Chi General HospitalRekrutteringIrritabelt tarmsyndrom | Funktionelle gastrointestinale lidelser | Sunde emner | Laryngopharyngeal refluksTaiwan
-
Mayo ClinicAfsluttetOrtostatisk hypotension | Autonomisk fiaskoForenede Stater
-
University of PadovaRekrutteringÅndedrætssvigt | Respiratory Distress Syndrome, VoksenItalien
-
Sheba Medical CenterAfsluttetReparation af kejsersnitIsrael